tiprankstipranks
OUE Lippo Healthcare Limited (SG:5WA)
SGX:5WA
Singapore Market

OUE Lippo Healthcare Limited (5WA) Share Price & Analysis

1 Followers

5WA Stock Chart & Stats

Day’s RangeS$0 - S$0
52-Week RangeS$0.03 - S$0.03
Previous CloseS$0.03
Volume100.00
Average Volume (3M)206.91K
Market Cap
S$124.41M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)15.6
Beta0.05
Aug 02, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding4,443,129,206
10 Day Avg. Volume80,460
30 Day Avg. Volume206,906
Standard Deviation0.22
R-Squared0.02
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

OUE Lippo Healthcare Limited News

Options Prices

Currently, No data available
---

Ownership Overview

9.14%0.00%0.00%90.86%
9.14%
Insiders
0.00% Other Institutional Investors
90.86% Public Companies and
Individual Investors

5WA FAQ

What was OUE Lippo Healthcare Limited’s price range in the past 12 months?
OUE Lippo Healthcare Limited lowest share price was S$0.03 and its highest was S$0.03 in the past 12 months.
    What is OUE Lippo Healthcare Limited’s market cap?
    Currently, no data Available
    When is OUE Lippo Healthcare Limited’s upcoming earnings report date?
    OUE Lippo Healthcare Limited’s upcoming earnings report date is Aug 02, 2024 which is in 73 days.
      How were OUE Lippo Healthcare Limited’s earnings last quarter?
      OUE Lippo Healthcare Limited released its earnings results on Feb 26, 2024. The company reported S$0.001 earnings per share for the quarter, beating the consensus estimate of N/A by S$0.001.
        Is OUE Lippo Healthcare Limited overvalued?
        According to Wall Street analysts OUE Lippo Healthcare Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does OUE Lippo Healthcare Limited pay dividends?
          OUE Lippo Healthcare Limited does not currently pay dividends.
          What is OUE Lippo Healthcare Limited’s EPS estimate?
          OUE Lippo Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does OUE Lippo Healthcare Limited have?
          OUE Lippo Healthcare Limited has 4,443,129,400 shares outstanding.
            What happened to OUE Lippo Healthcare Limited’s price movement after its last earnings report?
            OUE Lippo Healthcare Limited reported an EPS of S$0.001 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of OUE Lippo Healthcare Limited?
              Currently, no hedge funds are holding shares in SG:5WA
              ---

              OUE Lippo Healthcare Limited Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              0.00%
              12-Months-Change

              Fundamentals

              Return on Equity
              3.71%
              Trailing 12-Months
              Asset Growth
              3.25%
              Trailing 12-Months
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis